Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingqing Zhu

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Signal Transduction and Targeted Therapy|May 5, 2024
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trialBiqi Zhou, Jia Chen, Tianhui Liu, et al.
Annals of Hematology|May 1, 2026
CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemiaJinhong Nie, Lu Gao, Yingchun Shao, et al.
Discover Oncology|March 19, 2024
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myelomaMo Zhou, Yan Chen, Yanlei Gong, et al.
Journal of Hematology & Oncology|May 26, 2021
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationQingya Cui, Chongsheng Qian, Nan Xu, et al.
Cancer Medicine|December 28, 2020
Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myelomaLingzhi Yan, Su Qu, Jingjing Shang, et al.
Frontiers in Immunology|December 16, 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phaseQingya Cui, Peiqi Liang, Haiping Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2018
Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopeniaMengxing Chen, Rong Yan, Kangxi Zhou, et al.
American Journal of Hematology|February 3, 2022
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myelomaXiaolan Shi, Lingzhi Yan, Jingjing Shang, et al.
Journal of the National Cancer Center|March 5, 2025
Chinese expert consensus on flow cytometric detection of hematological malignant cells in tissue samplesZailin Yang, Xia Mao, Mingxia Zhu, et al.
Haematologica|November 27, 2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter studyMingkai Shu, Wenjing Ding, Linlin Wang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Signal Transduction and Targeted Therapy|May 5, 2024
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trialBiqi Zhou, Jia Chen, Tianhui Liu, et al.
Annals of Hematology|May 1, 2026
CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemiaJinhong Nie, Lu Gao, Yingchun Shao, et al.
Discover Oncology|March 19, 2024
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myelomaMo Zhou, Yan Chen, Yanlei Gong, et al.
Journal of Hematology & Oncology|May 26, 2021
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationQingya Cui, Chongsheng Qian, Nan Xu, et al.
Cancer Medicine|December 28, 2020
Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myelomaLingzhi Yan, Su Qu, Jingjing Shang, et al.
Frontiers in Immunology|December 16, 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phaseQingya Cui, Peiqi Liang, Haiping Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2018
Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopeniaMengxing Chen, Rong Yan, Kangxi Zhou, et al.
American Journal of Hematology|February 3, 2022
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myelomaXiaolan Shi, Lingzhi Yan, Jingjing Shang, et al.
Journal of the National Cancer Center|March 5, 2025
Chinese expert consensus on flow cytometric detection of hematological malignant cells in tissue samplesZailin Yang, Xia Mao, Mingxia Zhu, et al.
Haematologica|November 27, 2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter studyMingkai Shu, Wenjing Ding, Linlin Wang, et al.
Pageof 4